$PCRX SEC Filings

Filed On	Filing
13 Oct 2026	SCHEDULE 13D/A
09 Oct 2026	Form 4: Riker Lauren, Senior Vice President, Finance Received 6,000 shares by exercise or conversion ($194K) · Sold 6,000 shares ($218K)
08 Oct 2026	SC TO-C
08 Oct 2026	SC14D9C
08 Oct 2026	144
08 Oct 2026	8-K: Entry into a Material Definitive Agreement; Regulation FD Disclosure This Agreement and Plan of Merger (this “Agreement”) is made and entered into as of October 8, 2026 (the “Agreement Date”), by and among Viatris Inc., a Delaware corporation (“Parent”), Peach Purchaser Sub Inc., a Delaware corporation an...
08 Oct 2026	SC TO-C
18 Aug 2026	Form 4: Slonin Jonathan, Chief Medical Officer Sold 3,040 shares ($70.6K)
17 Aug 2026	144
07 Aug 2026	SCHEDULE 13G
04 Aug 2026	S-8
04 Aug 2026	10-Q - PCRX - 06.30.2026
04 Aug 2026	8-K: Results of Operations and Financial Condition
30 Jun 2026	8-K: Entry into a Material Definitive Agreement; Regulation FD Disclosure
12 Jun 2026	Form 4: Hirawat Samit, Director Received 6,405 shares as a grant or award · Granted 10,891 Stock Option (Right to Buy)
12 Jun 2026	Form 4: Riker Lauren, Senior Vice President, Finance Sold 6,115 shares ($144K)
12 Jun 2026	Form 4: Christie Christopher, Director Received 6,405 shares as a grant or award · Granted 10,891 Stock Option (Right to Buy)
12 Jun 2026	Form 4: Wiggans Thomas G, Director Granted 32,675 Stock Option (Right to Buy)
12 Jun 2026	Form 4: Young Alethia, Director Received 6,405 shares as a grant or award · Granted 10,891 Stock Option (Right to Buy)
12 Jun 2026	Form 4: Yang Michael J., Director Received 6,405 shares as a grant or award · Granted 10,891 Stock Option (Right to Buy)

Comments